Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma
Yichang Ren, Yuxi Wang, Jin Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6697-6714
Closed Access | Times Cited: 11

Showing 11 citing articles:

A Concise Review on Recent Development of Indole Derivatives for Anticancer Activities
B. T. Sridhar, Nagesh Gunavanthrao Yernale, Ramesh S. Gani, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101282-101282
Closed Access | Times Cited: 6
Discovery of Novel Isoquinoline Analogues as Dual Tubulin Polymerization/V-ATPase Inhibitors with Immunogenic Cell Death Induction
Jiafu Leng, Yongjun Zhao, Shifang Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 3144-3166
Closed Access | Times Cited: 5
Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities
Wen‐Bo Liu, Weiguang Yang, Ji Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117314-117314
Closed Access
Discovery of Novel Rigid STING PROTAC Degraders as Potential Therapeutics for Acute Kidney Injury
Rui Ma, Renquan Fu, Yifan Wang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117539-117539
Closed Access
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy
Chengyong Wu, Lele Zhang, Zhilan Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116649-116649
Closed Access | Times Cited: 2
Discovery of novel thiophene[3,2-d]pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma
Chenglong Xu, Chengyong Wu, Ling Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116791-116791
Closed Access | Times Cited: 2
A pan-cancer analysis of the association of METRN with prognosis and immune infiltration in human tumors
Wang Li, Guofu Huang, Han Xiao, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37213-e37213
Open Access | Times Cited: 2
Design, synthesis and anti-tumor evaluation of novel pyrimidine and quinazoline analogues
Ren-Jie Lin, Lin Xie, Tianyu Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117057-117057
Closed Access | Times Cited: 2
Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities
Xin-Yi Tian, Weixin Zhang, Jia Yu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116079-116079
Closed Access | Times Cited: 6
Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site
Yang Yang, Yan Cao, Jingwen Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116177-116177
Closed Access | Times Cited: 1
Advancements in Chemotherapeutic Drugs for Intensive Care Management of Hematological Malignancies
Shakti Bedanta Mishra
(2024), pp. 277-294
Closed Access
Page 1

Scroll to top